Woodline Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.36M | Buy |
246,145
+20
| +0% | +$517 | 0.03% | 518 |
|
|
2025
Q1 | $2.51M | Sell |
246,125
-85,509
| -26% | -$872K | 0.02% | 631 |
|
|
2024
Q4 | $4.63M | Buy |
331,634
+216,189
| +187% | +$3.02M | 0.03% | 500 |
|
|
2024
Q3 | $2.25M | Buy |
115,445
+73,918
| +178% | +$1.44M | 0.02% | 463 |
|
|
2024
Q2 | $772K | Buy |
+41,527
| New | +$772K | 0.01% | 475 |
|
|
2022
Q1 | – | Sell |
-65,774
| Closed | -$13.3M | – | 788 |
|
|
2021
Q4 | $13.3M | Buy |
+65,774
| New | +$13.3M | 0.19% | 147 |
|